{
  "cells": [
    {
      "cell_type": "raw",
      "metadata": {},
      "source": [
        "---\n",
        "title: \"Molecular Characterization of Multidrug-Resistant Tuberculosis Isolates from the National TB Reference Laboratory in Kenya by Whole Genome Sequencing\"\n",
        "author: Steve George Odette\n",
        "format: revealjs\n",
        "editor: visual\n",
        "slide-number: c/t\n",
        "height: 900\n",
        "width: 1600\n",
        "---"
      ],
      "id": "607a8321"
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "```{css, echo=FALSE}\n",
        ".title{\n",
        "font-size; 100px\n",
        "}\n",
        "\n",
        "```\n",
        "\n",
        "\n",
        "## Background of information\n",
        "\n",
        "-   Tuberculosis (TB) is a deadly infectious disease, claiming over 1.6 million lives annually (WHO, 2022)\n",
        "\n",
        "-   Multidrug-resistant TB (MDR-TB) poses a significant challenge globally, being resistant to key anti-TB drugs[^1] (WHO, 2022)\n",
        "\n",
        "[^1]: Isoniazid and Rifampicin\n",
        "\n",
        "\n",
        "```{=html}\n",
        "<!-- -->\n",
        "```\n",
        "\n",
        "-   Global MDR-TB cases increased by 3.2% to 450,000 in 2022 (WHO, 2022; Salari et al., 2023)\n",
        "\n",
        "-   East Africa has an MDR-TB estimate of 4% among newly diagnosed and 21% among previously treated individuals (Molla et al., 2022)\n",
        "\n",
        "-   Kenya, a high-TB burden country, had an estimated 5% MDR-TB prevalence in 2018 (Kerubo et al., 2022)\n",
        "\n",
        "## Background of information cont.\n",
        "\n",
        "-   MDR-TB imposes significant economic burdens, costing more to manage and affecting productivity[^2] (Ministry of Health Kenya, 2017; Kairu et al., 2021; Silva et al., 2021)\n",
        "\n",
        "-   Kenya lacks comprehensive epidemiological data on MDR-TB, especially from the National TB reference laboratory (NTRL) (Gichuki & Mategula, 2021)\n",
        "\n",
        "-   Molecular diagnostic tests like Xpert MTB/RIFÂ® and LPA have increased MDR-TB detection accuracy (Aricha et al., 2019)\n",
        "\n",
        "-   However, since 2015, Kenya lacked MDR-TB surveillance using NTRL data\n",
        "\n",
        "[^2]: Ksh. 145,109.53 compared to Ksh. 25,874.00 for drug-susceptible TB in 2017 (Ministry of Health Kenya., 2017)\n",
        "\n",
        "## Background of information cont.\n",
        "\n",
        "-   This study aims to comprehensively examine the epidemiology of MDR-TB in Kenya from 2015-2016, filling gaps in existing knowledge\n",
        "\n",
        "-   A retrospective cross-sectional study will analyze epidemiological and molecular data from the NTRL to identify trends and patterns of drug resistance\n",
        "\n",
        "-   The findings will aid targeted interventions like contact tracing and infection control measures based on transmission dynamics identified through genomic analysis\n",
        "\n",
        "## Research questions\n",
        "\n",
        "What is the molecular epidemiology of multi-drug resistant tuberculosis based on isolates receieved at the NTRL:\n",
        "\n",
        ":::{.incremental}\n",
        "\n",
        ":::{.fragment .highlight-red}\n",
        "\n",
        "-   What is the prevalence and phenotypic profiles of MDR isolates at NTRL?\n",
        "\n",
        ":::\n",
        "\n",
        "-   What are the gene mutations conferring MDR in isolates at the NTRL?\n",
        "\n",
        "-   Which gene mutations co-exist to confer MDR in isolates at the NTRL?\n",
        "\n",
        "-   What is the genetic diversity of MDR isolates at the NTRL?\n",
        "\n",
        ":::\n",
        "\n",
        "## Objectives\n",
        "\n",
        "**General objective**\n",
        "\n",
        "To characterize multidrug-resistant (MDR) tuberculosis (TB) isolates from the National TB Reference Laboratory using whole-genome sequencing\n",
        "\n",
        "## Objectives\n",
        "\n",
        "**General objective**\n",
        "\n",
        "To characterize multidrug-resistant (MDR) tuberculosis (TB) isolates from the National TB Reference Laboratory using whole-genome sequencing\n",
        "\n",
        "Specific objectives\n",
        "\n",
        ":::{.incremental}\n",
        "\n",
        ":::{.fragment .highlight-red}\n",
        "\n",
        "-   To determine the prevalence and phenotypic profiles of multi-drug-resistant *Mycobacterium tuberculosis* among TB samples from the NTRL\n",
        "\n",
        ":::\n",
        "\n",
        "-   To determine the mutations conferring drug resistance within drug target genes of the sequenced MDR isolates, their frequency, and distribution\n",
        "\n",
        "-   To determine the genetic diversity of MDR TB isolates from NTRL by Whole Genome Sequencing\n",
        "\n",
        "-   To evaluate co-existent gene mutations, their frequency, and distribution of isolates at the NTRL\n",
        "\n",
        ":::\n",
        "\n",
        "## Workflow\n",
        "\n",
        "OK\n",
        "\n",
        "## Methods\n",
        "\n",
        "-   Retrospective cross-sectional study investigating MDR-TB epidemiology using NTRL samples in Nairobi\n",
        "\n",
        "-   NTRL: Central repository for TB data, collecting nationwide information\n",
        "\n",
        "-   Data from 2015-2016, including all confirmed pulmonary TB cases entered into LIMS, were eligible\n",
        "\n",
        "-   Table 1: Laboratory procedures for diagnosing drug-resistant TB at NTRL in 2015\n",
        "\n",
        "-   Table 2: Variables available for 2015-2016 data, with 8308 entries analyzed\n",
        "\n",
        "## Methods cont.\n",
        "\n",
        "Data Analysis - pDST Arm\n",
        "\n",
        "-   Initial analysis using pDST data, dropping nulls to proceed with 1271 entries\n",
        "\n",
        "-   76 entries fit MDR definition and included in downstream analysis\n",
        "\n",
        "## Methods cont.\n",
        "\n",
        "Data Analysis - Analysis and Regression Model\n",
        "\n",
        "-   LPA data analysis: After removing nulls, 2621 entries remained\n",
        "\n",
        "-   Only verified MDR entries with full demographic data were included, resulting in 143 MDR cases\n",
        "\n",
        "-   R and R packages used for data analysis and visualizations\n",
        "\n",
        "-   Prevalence of MDR calculated by dividing MDR entries by total entries\n",
        "\n",
        "-   Statistical tests (Fisher's Exact Test, Wilcoxon rank sum test) with q-value correction used where applicable\n",
        "\n",
        "-   Logistic regression model with gender and type of TB patient as variables\n",
        "\n",
        "## RESULTS\n",
        "\n",
        "Demographic Summary\n",
        "\n",
        "-   Our study analyzed 1271 entries with pDST data (15% of 8308)\n",
        "\n",
        "-   MDR prevalence based on pDST data: 5.97% (76/1271)\n",
        "\n",
        "-   Males accounted for 62% of MDR cases, while females were 29%\n",
        "\n",
        "-   50% of MDR cases were HIV negative, 16% were HIV positive, and 22% had no HIV test\n",
        "\n",
        "-   Different TB patient categories were identified, with new TB patients and those on retreatment being the highest percentages"
      ],
      "id": "11f16bee"
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3",
      "language": "python",
      "name": "python3"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}